|
1
|
Zhang B, Nie X, Xiao B, Xiang J, Shen S,
Gong J, Zhou M, et al: Identification of tissue-specific genes in
nasopharyngeal epithelial tissue and differentially expressed genes
in nasopharyngeal carcinoma by suppression subtractive
hybridization and cDNA microarray. Genes Chromosomes Cancer.
38:80–90. 2003. View Article : Google Scholar
|
|
2
|
Nie XM, Zhang BC, Li XL, Xiang JJ, Xiao
BY, Ma J, Zhou M, et al: Cloning, expression and mutation analysis
of NOR1, a novel human gene down-regulated in HNE1
nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol.
129:410–414. 2003.PubMed/NCBI
|
|
3
|
Nie XM, Zhou M, Tang K, Zhang BC, Xiong W,
Lu HB, Li XL, et al: Molecular cloning and characterization of a
novel nitroreductase gene, NOR1, possibly involved in
chemical carcinogenesis of NPC. Chin J Biochem Mol Biol.
19:423–428. 2003.
|
|
4
|
Poirier S, Bouvier G, Malaveille C,
Ohshima H, Shao YM, Hubert A, Zeng Y, et al: Volatile nitrosamine
levels and genotoxicity of food samples from high-risk areas for
nasopharyngeal carcinoma before and after nirosation. Int J Cancer.
44:1088–1094. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Y, Ausman LM, Greenberg AS, Russell
RM and Wang XD: Nonalcoholic steatohepatitis induced by a high-fat
diet promotes diethylnitrosamine-initiate early
hepatocarcinogenesis in rats. Int J Cancer. 124:540–546. 2009.
View Article : Google Scholar
|
|
6
|
Liu C and Russell RM: Nutrition and
gastric cancer risk: an update. Nutr Rev. 66:237–249. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartsch H, Pignatelli B, Calmels S and
Ohshima H: Inhibition of nitrosation. Basic Life Sci. 61:27–44.
1993.
|
|
8
|
Lowenstein EJ, Daly RJ, Batzer AG, Li W,
Margolis B, Lammers R, Ullrich A, et al: The SH2 and SH3
domain-containing protein GRB2 links receptor tyrosine kinases to
ras signaling. Cell. 70:431–442. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rozakis-Adcock M, Fernley R, Wade J,
Pawson T and Bowtell D: The SH2 and SH3 domains of mammalian Grb2
couple the EGF receptor to the Ras activator mSos1. Nature.
363:83–85. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Skolnik EY, Batzer A, Li N, Lee CH,
Lowenstein E, Mohammadi M, Margolis B and Schlessinger J: The
function of GRB2 in linking the insulin receptor to Ras signaling
pathways. Science. 260:1953–1955. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Daly RJ, Gu H, Parmar J, Malaney S, Lyons
RJ, Kairouz R, Head DR, et al: The docking protein Gab2 is
overexpressed and estrogen regulated in human breast cancer.
Oncogene. 21:5175–5181. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nguyen DH, Webb DJ, Catling AD, Song Q,
Dhakephalkar A, Weber MJ, Ravichandran KS and Gonias SL:
Urokinase-type plasminogen activator stimulates the
Ras/extracellular signal-regulated kinase (ERK) signaling pathway
and MCF-7 cell migration by a mechanism that requires focal
adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc
complex is associated with the transient phosphorylation of ERK in
urokinase-treated cells. J Biol Chem. 275:19382–19388. 2000.
|
|
13
|
Normanno N, Campiglio M, Maiello MR, De
Luca A, Mancino M, Gallo M, D'Alessio A and Menard S: Breast cancer
cells with acquired resistance to the EGFR tyrosine kinase
inhibitor gefitinib show persistent activation of MAPK signaling.
Breast Cancer Res Treat. 112:25–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martínez N, García-Domínguez CA, Domingo
B, Oliva JL, Zarich N, Sánchez A, Gutiérrez-Eisman S, et al:
Sprouty2 binds Grb2 at two different proline-rich regions, and the
mechanism of ERK inhibition is independent of this interaction.
Cell Signal. 19:2277–2285. 2007.PubMed/NCBI
|
|
15
|
Diwan BA, Ramakrishna G, Anderson LM and
Ramljak D: Overexpression of Grb2 in inflammatory lesions and
preneoplastic foci and tumors induced by N-nitrosodimethylamine in
Helicobacter hepaticus-infected and -noninfected A/J mice. Toxicol
Pathol. 28:548–554. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li DQ, Tang H, Gui R and Nie XM: Changes
in global gene expression induced by NOR1 over
expression in HepG2 cells. Prog Biochem Biophys. 35:457–464.
2008.
|
|
17
|
Dachs GU, Tupper J and Tozer GM: From
bench to bedside for gene-directed enzyme prodrug therapy of
cancer. Anticancer Drugs. 16:349–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Djeha HA, Todryk SM, Pelech S, Wrighton
CJ, Irvine AS, Mountain A and Lipinski KS: Antitumor immune
responses mediated by adenoviral GDEPT using nitroreductase/CB1954
is enhanced by high-level coexpression of heat shock protein 70.
Cancer Gene Ther. 12:560–571. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helsby NA, Ferry DM, Patterson AV, Pullen
SM and Wilson WR: 2-Amino metabolites are key mediators of CB 1954
and SN 23862 bystander effects in nitroreductase GDEPT. Br J
Cancer. 90:1084–1092. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang MH, Helsby NA, Wilson WR and Tingle
MD: Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
Toxicology. 216:129–139. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clark SG, Stern MJ and Horvitz HR: C.
elegans cell-signalling gene sem-5 encodes a protein with SH2
and SH3 domains. Nature. 356:340–344. 1992. View Article : Google Scholar
|
